EUVIMEDEUVIMED entdecken
Crossref

OTUD1 inhibits endometriosis fibrosis by deubiquitinating MADH7

Xiangyu Chang, Yanqin Zhang, Mengqi Deng, Ruiye Yang, Jiamin Zhang, Menglin Hao, Jinwei Miao iD

Molecular Human Reproduction · 2025

DOI: 10.1093/molehr/gaaf014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Human Reproduction, 2025. Verfasst von Xiangyu Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Ho…. Hauptthemen laut MEDLINE: Endometriosis, Ubiquitin-Specific Proteases, Deubiquitinating Enzymes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Hospitals Authority's Ascent Plan, Beijing Hospitals Authority’s Ascent Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis constitutes the principal pathophysiological mediator of pain and infertility manifestations in endometriosis, and the inhibitory factor of the TGF-β pathway, MADH7, makes a vital impact on the progression of fibrosis. Ovarian tumor domain-containing protein 1 (OTUD1) deubiquitinase binds to the MADH7 protein, although its specific role in endometriosis needs to be investigated. This study is the first to explore the role of OTUD1 in endometriosis and to investigate its impact on the growth of endometriosis lesions in vitro and in vivo, using C57BL/6N female mice and human primary stromal endometriosis cells (HEMCs). Moreover, the obtained results demonstrated that OTUD1 inhibited the expression of fibrosis-related proteins in HEMCs in vitro, and the mechanistic execution of this phenotype was achieved via coordinated deubiquitination coupled with MADH7-mediated transcriptional reprogramming. These events stopped the growth of lesions in vivo and reduced abdominal inflammation. The study demonstrated the critical role of the deubiquitinating enzyme OTUD1 in endometriosis, indicating its potential therapeutic effect on endometriosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisUbiquitin-Specific ProteasesDeubiquitinating EnzymesFemaleAnimalsHumansMiceFibrosisMice, Inbred C57BLUbiquitinationStromal CellsEndometrium

Stichwörter der Autor:innen

MADH7OTUD1deubiquitinationendometriosisfibrosismice model

Substanzen

Ubiquitin-Specific ProteasesDeubiquitinating Enzymes

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.

ORCID-Profile: Jinwei Miao

Förderung

  • National Natural Science Foundation of China
  • Beijing Hospitals Authority's Ascent Plan
  • Beijing Hospitals Authority’s Ascent Plan

Zitieren

APA

Chang, X., Zhang, Y., Deng, M., Yang, R., Zhang, J., Hao, M., & Miao, J. (2025). OTUD1 inhibits endometriosis fibrosis by deubiquitinating MADH7. Molecular Human Reproduction. https://doi.org/10.1093/molehr/gaaf014

Vancouver

Chang X, Zhang Y, Deng M, Yang R, Zhang J, Hao M, et al. OTUD1 inhibits endometriosis fibrosis by deubiquitinating MADH7. Molecular Human Reproduction. 2025. doi:10.1093/molehr/gaaf014

BibTeX
@article{Chang2025,
  author = {Chang, Xiangyu and Zhang, Yanqin and Deng, Mengqi and Yang, Ruiye and Zhang, Jiamin and Hao, Menglin and Miao, Jinwei},
  title = {OTUD1 inhibits endometriosis fibrosis by deubiquitinating MADH7},
  journal = {Molecular Human Reproduction},
  year = {2025},
  doi = {10.1093/molehr/gaaf014}
}
Kostenlos starten →